Replies to post #124635 on Biotech Values

[DewDiligence]

3Q11 US Lovenox Sales by Product and Market Segment (estimated)

 
                      -$ Sales (mln)-   -----Share-----   
                      Branded Generic   Branded Generic 
 Hospital segment       159     107       60%     40%   
 Outpatient segment      25     152       14%     86%   
 ==================     ===     ===   
 Overall market         184     259       42%     58%

Assumptions:

1. The hospital segment comprises 60% of the market by dollar sales.
2. Sales in the outpatient setting are proportional to scripts (#msg-66940914).

(2Q11 numbers are shown in #msg-65934604.)